Although selective serotonin reuptake inhibitors (SSRIs) have been widely used in both psychiatry and other medicine, few cases have been reported SSRI-related hyperprolactinemia and/or galactorrhea. We experienced one case which showed both galactorrhea and hyperprolactinemia following treatment with paroxetine. In the case, a 37-year-old multiparous woman reported galactorrhea after 8-weeks paroxetine treatment for her depression. After 1 month prescription of bromocriptine, dopamine agonist, as well as switching medication from paroxetine to venlafaxine, serotonin-norepinephrine reuptake inhibitor, both galactorrhea and hyperprolactinemia were disappeared. Both hyperprolactinemia and galactorrhea have not been observed even after the cessation of bromocriptine prescription.
Adult ; Bromocriptine ; Cyclohexanols ; Depression ; Dopamine Agonists ; Female ; Galactorrhea ; Humans ; Hyperprolactinemia ; Paroxetine ; Pregnancy ; Prescriptions ; Serotonin Uptake Inhibitors ; Venlafaxine Hydrochloride

The aim of this study was to determine the adaptation of atrial natriuretic peptide(ANP) to simulated weightlessness. The level of immunoreactive plasma ANP level and the expression of right atrial ANP mRNA were assessed in male Sparague-Dawley rats during 2 weeks of head-down suspension(HDS) The rats were placed in a -45 degrees anti-orthostatic position. The plasma ANP level was investigated by radioimmunoassay and ANP mRNA was expressed by Northern blot analysis. The changes in daily water intake, body weight and arterial hematocrit did not show the statistical significances during HDS. The plasma ANP level slightly increased after 1 day of HDS, the response was transient and then decreased below the control levels. The expression of the ANP mRNA increased after 1 day, the peak value occurred at 3 days of HDS and thereafter ANP mRNA showed the similar patterns compared to the changes of plasma level. On the basis of these findings, we conclude that the initial adaptation of ANP to increased control blood volume in rats occurs between 3 and 7 days of HDS, and the ANP acts an important role during regulatory process to central hypervolemia at both synthetic and secretory levels within the early stage of HDS.
Animals ; Atrial Natriuretic Factor ; Blood Volume ; Blotting, Northern ; Body Weight ; Drinking ; Hematocrit ; Humans ; Male ; Plasma ; Radioimmunoassay ; Rats* ; RNA, Messenger* ; Weightlessness